HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anjali Pandey Selected Research

scirpusin A

1/2022The Anti-Obesity Potential of Cyperus rotundus Extract Containing Piceatannol, Scirpusin A and Scirpusin B from Rhizomes: Preclinical and Clinical Evaluations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anjali Pandey Research Topics

Disease

7Neoplasms (Cancer)
01/2019 - 02/2013
4Lymphoma (Lymphomas)
02/2017 - 12/2011
4Thrombosis (Thrombus)
11/2011 - 10/2010
3Inflammation (Inflammations)
01/2019 - 02/2012
3Hemorrhage
01/2018 - 07/2011
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2017 - 02/2013
2Cognitive Dysfunction
01/2018 - 09/2010
2Experimental Arthritis
01/2017 - 12/2014
2Arthritis (Polyarthritis)
04/2012 - 10/2009
2Neointima
11/2011 - 07/2002
1Overweight
01/2022
1Obesity
01/2022
1Weight Gain
01/2022
1Amyloid Plaque
01/2018
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2015
1Body Weight (Weight, Body)
01/2015
1Splenomegaly
12/2014
1B-Cell Leukemia (Leukemia, B Cell)
12/2014
1Prostatic Neoplasms (Prostate Cancer)
07/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2013
1Rheumatoid Arthritis
02/2012
1Vascular System Injuries
11/2011
1Vascular Remodeling
11/2011
1Wounds and Injuries (Trauma)
07/2011
1Thrombocytopenia (Thrombopenia)
02/2011
1Carotid Artery Thrombosis
10/2010
1Alzheimer Disease (Alzheimer's Disease)
09/2010
1Pleurisy (Pleuritis)
01/2010
1Infections
01/2009
1Leukemia
08/2002
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
08/2002
1Disease Progression
08/2002
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2002

Drug/Important Bio-Agent (IBA)

64- (cyclopropylamino)- 2- ((4- (4- (ethylsulfonyl)piperazin- 1- yl)phenyl)amino)pyrimidine- 5- carboxamideIBA
01/2019 - 12/2014
5Phosphotransferases (Kinase)IBA
05/2017 - 06/2002
4Syk KinaseIBA
01/2017 - 11/2011
3Janus Kinase InhibitorsIBA
01/2019 - 05/2017
3CytokinesIBA
04/2012 - 01/2010
32- (2- aminocyclohexylamino)- 4- (m- tolylamino)pyrimidine- 5- carboxamideIBA
12/2011 - 02/2011
2ibrutinibIBA
05/2017 - 02/2017
24- (3- (2H- 1,2,3- triazol- 2- yl)phenylamino)- 2- (2- aminocyclohexylamino)pyrimidine- 5- carboxamideIBA
01/2017 - 02/2013
2ferric chlorideIBA
07/2011 - 10/2010
22-hydroxychavicolIBA
09/2010 - 01/2009
1scirpusin AIBA
01/2022
1StilbenesIBA
01/2022
13,3',4,5'-tetrahydroxystilbeneIBA
01/2022
1scirpusin BIBA
01/2022
1Cholinergic Agents (Cholinergics)IBA
01/2018
1AnticoagulantsIBA
01/2018
1Neuroprotective AgentsIBA
01/2018
1withanoneIBA
01/2018
1Pharmaceutical PreparationsIBA
12/2015
1calebin-AIBA
01/2015
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
12/2014
1AutoantibodiesIBA
12/2014
1BromidesIBA
07/2013
1fludarabineIBA
02/2013
1pyrimidineIBA
11/2011
1Prasugrel HydrochlorideFDA Link
07/2011
1Clopidogrel (Plavix)FDA Link
07/2011
1ThienopyridinesIBA
07/2011
1elinogrelIBA
07/2011
1AntibodiesIBA
02/2011
1Antigen-Antibody Complex (Immune Complex)IBA
02/2011
1Heparin (Liquaemin)FDA LinkGeneric
02/2011
1Platelet Factor 4IBA
02/2011
1Thrombin Receptors (Thrombin Receptor)IBA
10/2010
1ThrombinFDA Link
10/2010
1Purinergic P2 Receptors (ADP Receptor)IBA
10/2010
1Proteinase-Activated ReceptorsIBA
10/2010
1Purinergic P2Y12 ReceptorsIBA
10/2010
1Interleukin-6 (Interleukin 6)IBA
09/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2010
1Interleukin-1beta (Interleukin 1 beta)IBA
09/2010
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
09/2010
1lupeolIBA
01/2010
1acetovanillone (apocynin)IBA
10/2009
1Sucrose (Saccharose)IBA
01/2009
1GlucansIBA
01/2009
1Anti-Bacterial Agents (Antibiotics)IBA
01/2009
1tandutinibIBA
06/2002

Therapy/Procedure

4Oral Administration
01/2022 - 07/2002
3Therapeutics
12/2011 - 06/2002
1Punctures
07/2011
1Catheters
07/2002